---
layout: post
title: "Animal Generic Drug User Fee Act; Public Meeting; Request for Comments"
date: 2026-02-05 19:00:56 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-21304
original_published: 2022-09-30 00:00:00 +0000
significance: 8.00
---

# Animal Generic Drug User Fee Act; Public Meeting; Request for Comments

**Published:** February 05, 2026 19:00 UTC
**Source:** Federal Register
**Original Published:** September 30, 2022 00:00 UTC
**Document Number:** 2022-21304

## Summary

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Animal Generic Drug User Fee Act." The purpose of the meeting is to discuss the proposed recommendations for the reauthorization of the Animal Generic Drug User Fee Act (AGDUFA IV) for fiscal years 2024 through 2028.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/09/30/2022-21304/animal-generic-drug-user-fee-act-public-meeting-request-for-comments)
- API: https://www.federalregister.gov/api/v1/documents/2022-21304

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
